(Q39835436)

English

Risk-adjusted therapy of acute lymphoblastic leukemia can decrease treatment burden and improve survival: treatment results of 2169 unselected pediatric and adolescent patients enrolled in the trial ALL-BFM 95.

scientific article

Statements

Risk-adjusted therapy of acute lymphoblastic leukemia can decrease treatment burden and improve survival: treatment results of 2169 unselected pediatric and adolescent patients enrolled in the trial ALL-BFM 95. (English)
Anja Möricke
Alfred Reiter
Martin Zimmermann
Helmut Gadner
Michael Dördelmann
Lutz Löning
Rita Beier
Wolf-Dieter Ludwig
Richard Ratei
Jochen Harbott
Joachim Boos
Georg Mann
Andreas Feldges
Günter Henze
Karl Welte
Jörn-Dirk Beck
Charlotte Niemeyer
Udo Bode
Christian Urban
Helmut Wehinger
Dietrich Niethammer
Hansjörg Riehm
German-Austrian-Swiss ALL-BFM Study Group
19 February 2008
4477-4489

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit